Table 1 Epidemiological data and refractive parameters. Displayed as aggregate data for each of the cylinder groups
Cylinder 0.25 | Cylinder 0.50 | Cylinder 0.75 | Total | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Number | % | Number | % | Number | % | Number | % | |||||||||
Eyes | 37 | 24,2 | 81 | 52,9 | 35 | 22,9 | 153 | 100 | ||||||||
Male | 17 | 45,95 | 39 | 48,15 | 18 | 51,43 | 74 | 48,37 | ||||||||
Female | 20 | 54,05 | 42 | 51,85 | 17 | 48,57 | 79 | 51,63 | ||||||||
Patients | 37 | 100 | 81 | 100 | 35 | 100 | 153 | 100 | ||||||||
Range | Mean(±SD) | Range | Mean(±SD) | Range | Mean(±SD) | Range | Mean(±SD) | |||||||||
Age (years)† | 23/60 | 38.84(10.56) | 20/61 | 39.68(10.65) | 24/63 | 43.49(9.28) | 20/63 | 40.35(10.42) | ||||||||
Days after OP‡ | 70/168 | 121.47(23.13) | 62/169 | 121.75(28.8) | 63/166 | 114.32(29.13) | 62/169 | 120.01(27.63) | ||||||||
PreOP | PostOP | PreOP | PostOP | PreOP | PostOP | PreOP | PostOP | |||||||||
SE | -2.88/-0.63 | -2(0.7) | -1/1 | 0.01 (0.42) | -3/-0.5 | -2.27 (0.68) | -1.5/1 | -0.06 (0.59) | -2.88/-0.63 | -1.96 (0.74) | -1.25/1.13 | -0.16 (0.61) | -3/-0.5 | -2.13 (0.71) | -1.5/1.13 | -0.06 (0.56) |
Subje ctiveS ph | -2.75/-0.5 | -1.88 (0.7) | -0.75/1.25 | 0.29 (0.42) | -2.75/-0.25 | -2.02 (0.68) | -1.25/1.5 | 0.27 (0.66) | -2.5/-0.25 | -1.59 (0.74) | -1/1.75 | 0.16 (0.63) | -2.75/-0.25 | -1.88 (0.72) | -1.25/1.75 | 0.25 (0.6) |
Subje ctiveC yl | -0.25/-0.25 | -0.25 (0) | -1.25/0 | -0.55 (0.29) | -0.5/-0.5 | -0.5(0) | -1.75/0 | -0.66 (0.4) | -0.75/-0.75 | -0.75 (0) | -1.5/0 | -0.65 (0.41) | -0.75/-0.25 | -0.5(0.17) | -1.75/0 | -0.63 (0.38) |
UDVA LogM | 0.1/2 | 0.78 (0.3) | -0.11 | 0.05 (0.1) | 0.1/2 | 0.84 (0.3) | -0.18 | 0.08 (0.1) | 0.1/2 | 0.75 (0.4) | -0.18 | 0.07 (0.1) | 0.1/2 | 0.81 (0.3) | -0.18 | 0.07 (0.1) |